FDA Approved: SUMATRIPTAN SUCCINATE — Supplemental Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

The FDA approved a supplemental application from Dr. Reddy's Laboratories Limited for Sumatriptan succinate, a generic treatment for acute migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Sumatriptan succinate (Sumatriptan succinate)

Snippet

SUPPL AP for SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE)